Mack Gene 4
4 · Gain Therapeutics, Inc. · Filed Mar 21, 2025
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-20+200,000→ 200,000 totalExercise: $2.29Exp: 2035-03-20→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest as to 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.